Bowel cancer
Intestinal cancer (carcinoma of rectum) is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 60%). The vast majority of patients are over 40 years old, and about 15% are under 30 years old. It is more common in men, with a male-to-female ratio of 2-3:1. Intestinal cancer should be actively prevented.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Blood in stool Loss of appetite Weight loss Feeling of incomplete defecation Abnormal bowel movement frequency -
Concurrent disease:
Related Drugs
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
GuangXi HeFeng Pharmaceutical Limited Liability Company
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Hainan Weikang Pharmaceutical(Qianshan) Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Harbin Medical University Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Harbin Medical University Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Harbin Medisan Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Heilongjiang Dilong Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Harbin Shengtai Biopharmaceutical Co., Ltd.
Calcium folinate for injection
Indication: It is mainly used as an antidote for folic acid antagonists (such as methotrexate, pyrimethamine or trimethoprim). This product is often used clinically to prevent severe toxic effects caused by overdose or high-dose treatment of methotrexate. When oral folic acid is ineffective, it is also used for megaloblastic anemia caused by stomatitis, diarrhea, malnutrition, pregnancy or infancy, but it is not suitable for vitamin B12 deficiency anemia. In recent years, calcium folinate has been used as an adjuvant treatment for colon and rectal cancer, and combined with fluorouracil, it can prolong survival.
Calcium folinate for injection
Indication: 1. Used as an antidote for folic acid antagonists (such as methotrexate, pyrimethoprim or trimethoprim). 2. Used to prevent severe toxic effects caused by overdose or high-dose treatment with methotrexate. 3. Also used to treat megaloblastic anemia caused by folic acid deficiency. 4. Used in combination with 5-fluorouracil for advanced colon and rectal cancer.
Manufacturer:
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Calcium folinate for injection
Indication: 1. Used as an antidote for folic acid antagonists (such as methotrexate, pyrimethoprim or trimethoprim). 2. Used to prevent severe toxic effects caused by overdose or high-dose treatment with methotrexate. 3. Also used to treat megaloblastic anemia caused by folic acid deficiency. 4. Used in combination with 5-fluorouracil for advanced colon and rectal cancer.
Manufacturer:
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Related Ingredients